The introduction of nicotinamide to be a nicotine substitution in e-cigarette and smokeless items represents a substantial regulatory obstacle with the FDA. Nicotinamide does not have nicotinic receptor agonist exercise and is thought to act as a sedative at significant dosages6. The claims made by Nicotine River, ECBlend, as well as other supplier